Conventional MRI radiomics in patients with suspected early- or pseudo-progression

BACKGROUND: After radiochemotherapy, 30% of patients with early worsening MRI experience pseudoprogression (Psp) which is not distinguishable from early progression (EP). We aimed to assess the diagnostic value of radiomics in patients with suspected EP or Psp. METHODS: Radiomics features (RF) of 76...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurooncol Adv
Autors principals: Bani-Sadr, Alexandre, Eker, Omer Faruk, Berner, Lise-Prune, Ameli, Roxana, Hermier, Marc, Barritault, Marc, Meyronet, David, Guyotat, Jacques, Jouanneau, Emmanuel, Honnorat, Jerome, Ducray, François, Berthezene, Yves
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Clinical Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7212855/
https://ncbi.nlm.nih.gov/pubmed/32642655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz019
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars